BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25409711)

  • 21. MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.
    Siragusa M; Zerilli M; Iovino F; Francipane MG; Lombardo Y; Ricci-Vitiani L; Di Gesù G; Todaro M; De Maria R; Stassi G
    Cancer Res; 2007 Jun; 67(11):5522-30. PubMed ID: 17545635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells.
    Senigagliesi B; Penzo C; Severino LU; Maraspini R; Petrosino S; Morales-Navarrete H; Pobega E; Ambrosetti E; Parisse P; Pegoraro S; Manfioletti G; Casalis L; Sgarra R
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance.
    Loria R; Laquintana V; Bon G; Trisciuoglio D; Frapolli R; Covello R; Amoreo CA; Ferraresi V; Zoccali C; Novello M; Del Bufalo D; Milella M; Biagini R; D'Incalci M; Falcioni R
    Oncogene; 2018 Nov; 37(45):5926-5938. PubMed ID: 29980789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
    Akhter MZ; Sharma A; Rajeswari MR
    Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of high-mobility group A proteins in the DNA damage signaling for the induction of apoptosis.
    Fujikane R; Komori K; Sekiguchi M; Hidaka M
    Sci Rep; 2016 Aug; 6():31714. PubMed ID: 27538817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
    BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Horm Metab Res; 2013 Jun; 45(6):408-14. PubMed ID: 23386415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Livin gene plays a role in drug resistance of colon cancer cells.
    Wang X; Xu J; Ju S; Ni H; Zhu J; Wang H
    Clin Biochem; 2010 May; 43(7-8):655-60. PubMed ID: 20171199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme.
    Liu B; Pang B; Liu H; Arakawa Y; Zhang R; Feng B; Zhong P; Murata D; Fan H; Xin T; Zhao G; Liu W; Guo H; Luan L; Xu S; Miyamoto S; Pang Q
    Pathol Res Pract; 2015 Aug; 211(8):596-600. PubMed ID: 26092597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
    Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
    Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-Mediated Regulation of HMGA1 Function.
    Benecke AG; Eilebrecht S
    Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A.
    Adair JE; Maloney SC; Dement GA; Wertzler KJ; Smerdon MJ; Reeves R
    Cancer Res; 2007 Jul; 67(13):6044-52. PubMed ID: 17616660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins.
    Maloney SC; Adair JE; Smerdon MJ; Reeves R
    DNA Repair (Amst); 2007 Sep; 6(9):1371-9. PubMed ID: 17540622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas.
    Martinez Hoyos J; Ferraro A; Sacchetti S; Keller S; De Martino I; Borbone E; Pallante P; Fedele M; Montanaro D; Esposito F; Cserjesi P; Chiariotti L; Troncone G; Fusco A
    Oncogene; 2009 Feb; 28(6):876-85. PubMed ID: 19060921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis.
    Rashmi R; Kumar S; Karunagaran D
    Carcinogenesis; 2004 Feb; 25(2):179-87. PubMed ID: 14604899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
    Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251.
    Fan H; Guo H; Zhang IY; Liu B; Luan L; Xu S; Hou X; Liu W; Zhang R; Wang X; Pang Q
    Brain Res; 2011 Apr; 1384():9-14. PubMed ID: 21300033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression.
    McDonald GT; Sullivan R; Paré GC; Graham CH
    Exp Cell Res; 2010 Nov; 316(19):3197-206. PubMed ID: 20736003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.